Pediatric Tachycardia Management

Initial Assessment and Stabilization

The American Heart Association recommends immediate assessment of hemodynamic stability in pediatric patients with palpable tachycardia, and proceeding directly to synchronized cardioversion at 0.5-1 J/kg if the child shows signs of shock, altered mental status, or cardiovascular compromise 1
For hemodynamically stable patients, the priority is obtaining a 12-lead ECG while simultaneously establishing monitoring and IV access, as recommended by the American College of Cardiology 1, 2
Maintaining a patent airway and administering supplemental oxygen if hypoxemia is present is crucial, as hypoxemia can drive tachycardia 1
The American Academy of Pediatrics recommends attaching a cardiac monitor/defibrillator to continuously monitor rhythm 1
Establishing IV or intraosseous (IO) access as soon as possible is essential for administering medications and fluids 1
Continuous monitoring of blood pressure and pulse oximetry is necessary to assess the patient's hemodynamic status 1

The 12-lead ECG determines the entire management pathway by answering three key questions: QRS duration, P-wave morphology and relationship to QRS, and presence of pre-excitation, as recommended by the American Heart Association 1, 2
The American College of Cardiology recommends analyzing the QRS duration to differentiate between narrow and wide complex tachycardia 3, 4
The presence of pre-excitation (delta waves suggesting Wolff-Parkinson-White syndrome) requires immediate cardiology referral, as recommended by the American Heart Association 2

The American Heart Association recommends differentiating sinus tachycardia from supraventricular tachycardia (SVT) using the 12-lead ECG and clinical context 3, 4, 1
For sinus tachycardia, treating the underlying cause rather than the heart rate itself is recommended by the American College of Cardiology 2, 5
The upper limit of physiologic sinus tachycardia is approximately 220 minus the patient's age, as recommended by the American Academy of Pediatrics 2
For supraventricular tachycardia, attempting vagal maneuvers first (Class IIa recommendation) unless the patient is hemodynamically unstable or this will delay definitive treatment is recommended by the American Heart Association 3, 4, 1
Adenosine is the drug of choice for SVT (Class I recommendation), with an initial dose of 0.1 mg/kg rapid IV/IO bolus (maximum first dose 6 mg) 1
Synchronized cardioversion (0.5-1 J/kg, increasing to 2 J/kg if needed) is recommended for refractory SVT 1

The American Heart Association recommends immediate referral to pediatric cardiology for pre-excitation (Wolff-Parkinson-White syndrome) on ECG, syncope during tachycardia or with exercise, wide complex tachycardia of unknown origin, and documented sustained SVT 2
Consultation with an expert in pediatric arrhythmias is strongly recommended before treating hemodynamically stable children, as all arrhythmia therapies have potential for serious adverse effects 3, 4, 1

The American College of Cardiology recognizes that persistent tachycardia (weeks to months) with fast ventricular response can cause tachycardia-mediated cardiomyopathy, which is reversible but requires careful long-term follow-up even after recovery 2
Risk stratification with ambulatory 24-hour monitoring or treadmill exercise testing is often considered for children with pre-excitation to assess persistence, as recommended by the American Heart Association 6, 7

Atomoxetine increases heart rate and blood pressure in 5-15% of patients, which could be contributing to the tachycardia, according to the American Academy of Pediatrics 8
Consider holding atomoxetine temporarily until the tachycardia mechanism is clarified, particularly if the ECG shows sinus tachycardia that may be medication-induced, as recommended by the American Academy of Pediatrics 8
Obtain personal and family cardiac history, including sudden death, cardiovascular symptoms, Wolff-Parkinson-White syndrome, hypertrophic cardiomyopathy, and long QT syndrome, and consider cardiology referral before continuing ADHD medications, as suggested by the American Academy of Pediatrics 8

For hemodynamically stable supraventricular tachycardia (SVT), attempt vagal maneuvers first, unless this will delay definitive treatment, as recommended by the American Heart Association 9
Adenosine is not explicitly mentioned as the drug of choice in this context, but the American Heart Association recommends it for SVT treatment 9
Do not give verapamil to children without expert consultation, particularly in this age group, as warned by the American Heart Association 9